Perrigo Company plc (LON:0Y5E)
London · Delayed Price · Currency is GBP · Price in USD | Market Cap | 1.04B -62.5% |
| Revenue (ttm) | 3.14B -3.6% |
| Net Income | -1.37B |
| EPS | -9.86 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | 4.54 |
| Dividend | 0.87 (11.44%) |
| Ex-Dividend Date | May 29, 2026 |
| Volume | 249 |
| Open | 9.98 |
| Previous Close | 9.73 |
| Day's Range | 9.67 - 10.07 |
| 52-Week Range | 9.28 - 28.52 |
| Beta | 0.52 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 5, 2026 |
About Perrigo Company
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pai... [Read more]
Financial Performance
In 2025, Perrigo Company's revenue was $4.25 billion, a decrease of -2.75% compared to the previous year's $4.37 billion. Losses were -$1.43 billion, 729.7% more than in 2024.
Financial numbers in USD Financial StatementsNews
Perrigo CEO Ousted Over Personal Conduct
Perrigo Chief Executive Patrick Lockwood-Taylor has resigned after the board found his personal conduct had violated company code.
Perrigo Announces Leadership Transition
Albert A. Manzone Appointed Interim President and CEO Patrick Lockwood-Taylor Resigns as President and CEO and as a Member of the Board DUBLIN, June 8, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: ...
Perrigo to Present at the Oppenheimer 26th Annual Consumer Growth & E-Commerce Conference
DUBLIN, May 26, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading global provider of consumer products, today announced that President and CEO Patrick Lockwood-Taylor and CFO Eduardo Be...
Perrigo Company Earnings Call Transcript: Q1 2026
First quarter 2026 saw sales and margins pressured by weak cough/cold demand and retailer destocking, but market share gains and cost savings supported results. Full-year guidance is reaffirmed, with improvement expected in the second half as headwinds ease.
Perrigo Company Earnings release: Q1 2026
Perrigo Company released its Q1 2026 earnings on May 6, 2026, summarizing the period's financial results.
Perrigo Company Slides: Q1 2026
Perrigo Company has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 6, 2026.
Perrigo Company Quarterly report: Q1 2026
Perrigo Company has published its Q1 2026 quarterly earnings report on May 6, 2026.
Perrigo Reports First Quarter 2026 Financial Results From Continuing Operations
Mitigating category headwinds with market share gains through implementation of Three‑S plan. Specialty Care segment achieved net sales and segment operating income growth, led by continued momentum i...
Perrigo Completes Divestiture of Dermacosmetics Business
Advances key Three-S plan pillar, streamlining portfolio Upfront net proceeds of approximately €306 million will enable debt reduction DUBLIN, April 30, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE:...
Perrigo Announces Quarterly Dividend
DUBLIN, April 29, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading global provider of consumer products, today announced that its Board of Directors has approved a quarterly dividend o...
Perrigo to Release First Quarter 2026 Financial Results on May 6, 2026
DUBLIN, April 22, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of consumer health products, today announced that it plans to issue its first quarter 2026 financial results...
Perrigo Company Proxy statement: Proxy filing
Perrigo Company filed a proxy statement on April 3, 2026, providing details for shareholder voting and corporate governance matters.
Perrigo Company Proxy statement: Proxy filing
Perrigo Company filed a proxy statement on March 20, 2026, providing details for shareholder voting and corporate governance matters.
Perrigo Company Proxy statement: Proxy filing
Perrigo Company filed a proxy statement on March 20, 2026, providing details for shareholder voting and corporate governance matters.
Perrigo Company Transcript: UBS Global Consumer and Retail Conference
A leading OTC health provider reported strong market share gains, significant cost savings, and a focused strategy on innovation, portfolio simplification, and disciplined capital allocation. Despite market softness, stabilization is expected in H2 2026, with long-term growth driven by brand building and geographic expansion.
Perrigo Company Slides: UBS Global Consumer and Retail Conference
Perrigo Company has posted slides in relation to its latest quarterly earnings report, which was published on March 11, 2026.
Perrigo to Present at the UBS Global Consumer and Retail Conference
DUBLIN, Ireland, March 3, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading global provider of consumer products, today announced that President and CEO Patrick Lockwood-Taylor is sched...
Perrigo Company Earnings Call Transcript: Q4 2025
Delivered strong share gains and EPS growth in 2025 despite market softness, with 2026 set as a transition year facing temporary headwinds but expecting improvement in the second half. Operational enhancements and portfolio streamlining continue, with a focus on innovation and cost savings.
Perrigo Company Annual report: Q4 2025
Perrigo Company has published its Q4 2025 annual report on February 26, 2026.
Perrigo Company Earnings release: Q4 2025
Perrigo Company released its Q4 2025 earnings on February 26, 2026, summarizing the period's financial results.
Perrigo Company Slides: Q4 2025
Perrigo Company has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on February 26, 2026.
Perrigo Reports Fourth Quarter and Fiscal Year 2025 Financial Results From Continuing Operations
Delivered FY2025 Adj. EPS at the Midpoint of Updated Outlook Range Advanced '3-S Plan' with Perrigo Store Brand OTC and Key Brands Gaining Share 1,2 in 2025, Despite Soft Category Consumption Launchin...
Perrigo to Release Fourth Quarter and Fiscal Year 2025 Financial Results on February 26, 2026
DUBLIN, Feb. 13, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of consumer health products, today announced that it plans to issue its fourth quarter and fiscal year 2025 f...
Did You Lose Money in Perrigo Company? PRGO Stockholders Should Contact Robbins LLP for Information About Their Rights Against PRGO.
SAN DIEGO--(BUSINESS WIRE)---- $PRGO #Health--Robbins LLP: Company: Perrigo Company (NYSE: PRGO) provides over-the-counter health and wellness solutions in the U.S., Europe, and internationally. What ...